H40.43X3 Glaucoma secondary to eye inflammation, bilateral, severe stage

Name of the Condition

• Glaucoma Secondary to Eye Inflammation, Bilateral, Severe Stage

Summary

Glaucoma secondary to eye inflammation, bilateral, severe stage, is a condition where increased intraocular pressure (IOP) or optic nerve damage occurs as a result of inflammatory processes affecting both eyes. This form of glaucoma may develop due to acute or chronic inflammation disrupting the eye’s drainage structures or optic nerve, potentially leading to vision loss if not managed. The term "bilateral" specifies that both eyes are affected, while "severe stage" indicates the condition is in an advanced phase of progression.

Causes

The condition arises from inflammation that disrupts the eye’s normal fluid drainage or damages the optic nerve. Common mechanisms include uveitis, scleritis, or other inflammatory disorders that affect the trabecular meshwork, angle structures, or optic nerve head. Inflammation may be acute (sudden onset) or chronic (long-standing), and the underlying cause of the inflammation (e.g., autoimmune, infectious) is not specified in this code.

Risk Factors

• Chronic or recurrent eye inflammation (e.g., uveitis).
• Autoimmune conditions (e.g., rheumatoid arthritis, sarcoidosis).
• Infections affecting the eye (e.g., viral or bacterial).
• Prior eye surgery or trauma that triggers inflammation.
• Use of topical or systemic medications that induce inflammation.

Symptoms

• Severe eye pain or discomfort.
• Blurred or reduced vision, especially in peripheral fields.
• Halos around lights.
• Redness in the eyes.
• Nausea or vomiting (in acute cases).
• Headaches.

Diagnosis

Diagnosis involves a comprehensive eye examination, including measurement of intraocular pressure (IOP), assessment of the optic nerve for damage, and evaluation of the eye’s drainage structures. Visual field testing may be used to detect vision loss. Inflammatory markers or imaging (e.g., optical coherence tomography) may help identify underlying inflammation. Documentation of bilateral involvement and severe stage is required for accurate coding.

Treatment Options

Treatment focuses on reducing inflammation and lowering IOP. This may include anti-inflammatory medications (e.g., corticosteroids), IOP-lowering drugs (e.g., prostaglandin analogs, beta-blockers), or surgical interventions (e.g., trabeculectomy, glaucoma drainage devices). Severe cases may require aggressive therapy to prevent irreversible vision loss.

Prognosis and Follow-Up

Prognosis depends on the extent of optic nerve damage and response to treatment. Severe stage glaucoma carries a higher risk of permanent vision loss if not managed promptly. Regular follow-up appointments are essential to monitor IOP, optic nerve health, and treatment efficacy. Adjustments to therapy may be necessary over time.

Complications

• Permanent vision loss or blindness.
• Optic nerve atrophy.
• Corneal damage from chronic inflammation.
• Cataracts (due to prolonged steroid use).
• Increased risk of secondary infections.

Lifestyle & Prevention

• Manage underlying inflammatory conditions (e.g., autoimmune diseases) with appropriate treatment.
• Avoid eye trauma or injury.
• Use protective eyewear in high-risk environments.
• Follow prescribed medication regimens consistently.
• Maintain regular eye examinations, especially if at risk for inflammation-related glaucoma.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden severe eye pain, vision loss, or symptoms like halos around lights. Regular check-ups are necessary for those with a history of eye inflammation or glaucoma to monitor for progression.

Tips for Medical Coders

Document the bilateral nature of the condition and confirm the severe stage of glaucoma secondary to eye inflammation. Ensure clinical notes specify both eyes are affected and the advanced progression of the disease. This code is specific to severe stage; avoid using it for mild or moderate cases. Verify that inflammation is the primary cause of the glaucoma, as this distinguishes it from other secondary glaucoma types.